Biop's Board Members
Sidney Braginsky - Chairman of the board
Mr. Sidney Braginsky has been President, CEO and Chairman of the Board of Atropos Technology, LLC since July 2000. In the past, he served as Chairman and Managing Director of Double D and Chairman and CEO of Digilab LLC.
Mr. Braginsky served as President of Olympus America, Inc. between 1994 and 1999.
In this role, he built a billion dollar business focused on optical products including cameras and scientific instruments (microscopes, endoscopes and chemistry analyzers). Mr. Braginsky also served as President and CEO of Mediscience Technology Corp., a designer and developer of diagnostic medical devices.
Mr. Braginsky is the former Chairman of International Standards Organization's (ISO's) Optics and Electro-Optical Systems, representing DIN. and served as the U.S. Leader of the same ISO group.
Currently, Mr. Braginsky serves on the boards of over 10 technological and bio-med companies.
Mr. Braginsky attended Queens College, City University of NY, majoring in Biology and Chemistry.
Dr. Dalit Milo, Ph.D
Dr. Dalit Landesman Milo is a Research associate in the Laboratory of Nanomedicine in the department of Cell research & Immunology at Tel-Aviv University. She is a project manager taking part in a national consortium in the field of utilizing targeted nano-delivery systems for cancer therapy. Dalit has an extensive background in the industrial biotech field.
Dr. Milo was a senior scientist in the bio-efficacy team in Compugen Ltd (CGEN). Then she established BioArt, a private biotechnology company that focused on developing and manufacturing innovative biotechnology-based therapeutic recombinant proteins.
Dr. Milo holds a Ph.D degree in human genetics from Sackler Medical school, M.Sc degree in Biochemistry and B.Sc degree all from Tel-Aviv University.
Atty. Ehud (Udi) Gindes is a founding partner at Goldblatt Gindes Yariv Advocates. Atty. Gindes has extensive experience in consulting public and private companies, specializing in investing contracts, mergers and acquisitions, founder agreements, capital raising and more. In addition, Atty. Gindes specializes in corporate recovery and creditor protection proceeding.
Atty. Gindes serves as a director at public and government companies, and served as a lecturer at the Interdisciplinary Center Herzliya for courses in corporate recovery, for for graduate law and business.
Atty. Gindes holds an LLB (with honors), and an LLM in the commercial law track both from Tel Aviv University.
Mr. Tang has 10 years of experience in financial advisory and fund management in Wall Street and in Shanghai.
His investment firm has become one of the most prominent dealmakers in the medical technology community, especially in northeast Ohio’s medical technology community.
Since 2006, Mr. Tang's company, Shanghai Creation Investment Management Co, Ltd. (SCI), raised over 500 Million USD and made PE investment of 40 Million USD in multiple projects.
Mr. Tang holds an MA in Finances from Columbia University, NY.
Dr. Thomas Denberg, MD, PhD
Dr. Denenberg is an Executive VP and Chief Strategy officer at Clarion Clinic, a not-for-profit network of 7 hospitals and numerous ambulatory facilities in Virginia. Dr. Denberg is the founding principal of Medzerez Healthcare Consultancy, and serves as the chair of the American College of Physicians Clinical Guidelines Committee. Dr. Denberg served as VP of Quality and Patient Safety at Atrius Health and Harvard Vanguard Medical Associates and as a medical director at the University of Colorado.
Currently, Dr. Denberg is a professor of medicine at the Virginia Tech Carilion School of medicine, and has published over 50 peer reviewed publications in the fields of population health management, quality improvement, patient-centered care, health disparities, and clinical practice guidelines.